Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 2a, Placebo-controlled Trial to Evaluate the Impact of Intravenous Bendavia™ on Ischemia Reperfusion Injury in Atherosclerotic Renal Artery Stenosis in Patients Undergoing Percutaneous Transluminal Angioplasty of the Renal Artery

Next Previous
Search
Trial Profile

A Phase 2a, Placebo-controlled Trial to Evaluate the Impact of Intravenous Bendavia™ on Ischemia Reperfusion Injury in Atherosclerotic Renal Artery Stenosis in Patients Undergoing Percutaneous Transluminal Angioplasty of the Renal Artery

Status: Discontinued
Phase of Trial: Phase II

Latest Information Update: 12 Aug 2020

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Elamipretide (Primary)
  • Indications Reperfusion injury
  • Focus Pharmacodynamics
  • Acronyms EVOLVE
  • Sponsors Stealth BioTherapeutics

Most Recent Events

  • 18 Nov 2016 Results published in a Stealth BioTherapeutics media release.
  • 18 Nov 2016 Results presented at the American Society of Nephrology (ASN) Kidney Week 2016, according to a Stealth BioTherapeutics media release.
  • 07 Nov 2016 Data from this trial will be presented at the American Society of Nephrology (ASN) Kidney Week 2016, according to a Stealth BioTherapeutics media release.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top